Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Astrazeneca Plc ADR
(NQ:
AZN
)
79.75
+0.38 (+0.48%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Jun 25, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Astrazeneca Plc ADR
< Previous
1
2
...
14
15
16
17
18
19
20
21
22
...
55
56
Next >
Sanofi, AstraZeneca Release Real-World Data For Respiratory Syncytial Virus Antibody
May 12, 2023
The race to tap the respiratory syncytial virus (RSV) this season intensifies as Sanofi SA (NASDAQ: SNY) and AstraZeneca Plc (NASDAQ: AZN) have
Via
Benzinga
Sanofi Says Its RSV Shot Significantly Cut Hospitalization Risk In Newborns
May 12, 2023
The monoclonal antibody shot significantly reduced the risk of hospitalization in babies.
Via
Investor's Business Daily
What Does AstraZeneca's Debt Look Like?
May 09, 2023
Via
Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
May 09, 2023
Via
Benzinga
How To Trade US CPI: The Top 5 Mega-Cap Gainers And Losers Following Last 3 Inflation Reports
May 09, 2023
Investors are eagerly awaiting the U.S. inflation statistics for April, which will be announced on Wednesday at 8.30 a.m. ET, before the start of trading on Wall Street.
Via
Benzinga
$1000 Invested In This Stock 15 Years Ago Would Be Worth $3,700 Today
May 03, 2023
Via
Benzinga
AstraZeneca Plc (AZN) Q1 2023 Earnings Call Transcript
April 28, 2023
AZN earnings call for the period ending March 31, 2023.
Via
The Motley Fool
FARXIGA extended in the US to reduce risk of cardiovascular death and hospitalization for heart failure to a broader range of patients
May 09, 2023
From
AstraZeneca
Via
Business Wire
Royalty Pharma Reaffirms FY23 Guidance Post Mixed Q1 Performance
May 09, 2023
Via
Benzinga
The 7 Best Mutual Funds to Invest in for May 2023
May 08, 2023
With rising uncertainties in the economy and the capital markets, investors have an incentive to consider the best mutual funds.
Via
InvestorPlace
WHO Ends Global Emergency Status for COVID-19 3 Years After Declaration, CDC Director Resigns
May 08, 2023
The World Health Organization ended the global emergency
Via
Benzinga
Earnings Outlook For AstraZeneca
April 26, 2023
Via
Benzinga
AstraZeneca PLC (NASDAQ: AZN) Records 52-Week High Friday Morning
April 21, 2023
Via
Investor Brand Network
A Look Into AstraZeneca's Debt
April 19, 2023
Via
Benzinga
GSK: Add This Cheap Chip Play To Your Portfolio
May 06, 2023
GSK pays a decent quarterly dividend. The latest declared dividend is $0.35 per share, giving GSK a yield of 3.85%.
Via
Talk Markets
3 Low-Volatility Stocks for a Stable Investment Strategy
May 06, 2023
These are the low-volatility stocks to buy for high total returns as they represent attractively-valued dividend names.
Via
InvestorPlace
High-Yield Pfizer Falls Off The COVID Cliff, And Survives
May 02, 2023
Pfizer is a value and high-yield compared to its peers and it it outperforming expectations in 2023; The pipeline is robust.
Via
MarketBeat
Topics
Intellectual Property
Exposures
COVID-19
Intellectual Property
FDA Advisory Committee Votes Favoring Restricted Use Of AstraZeneca/Merck's Prostate Cancer Drug
May 01, 2023
Via
Benzinga
FDA Casts Doubt on Merck/AstraZeneca's Cancer Drug for Prostate Cancer Ahead of Adcomm Meeting
April 27, 2023
The FDA's Oncologic Drugs Advisory Committee will be meeting tomorrow, Friday, 28 April, to discuss the supplemental new drug application (sNDA) for Lynparza (olaparib) in combination with abiraterone...
Via
Benzinga
Price Over Earnings Overview: AstraZeneca
April 18, 2023
Via
Benzinga
AstraZeneca PLC (NASDAQ: AZN) Records 52-Week High Tuesday Morning
April 18, 2023
Via
Investor Brand Network
Here's How Much $1000 Invested In AstraZeneca 5 Years Ago Would Be Worth Today
April 17, 2023
Via
Benzinga
AstraZeneca's COVID-19 Vaccine Loses Shine, Cancer Drug Imfinzi & Emerging Markets Stabilize Q1 Revenues
April 27, 2023
AstraZeneca Plc (NASDAQ: AZN) has reported Q1 FY23 core EPS of $1.92, up 1% Y/Y (+6% on constant currency), better than the consensus of $1.07. The company clocked Q1 sales of $10.88 billion, -4% (flat...
Via
Benzinga
7 Low-Risk Stocks to Buy if You Only Want to Beat Inflation
April 26, 2023
Getting in on some low-risk stocks is a good idea if you want to preserve your capital during inflation and before the upcoming recession.
Via
InvestorPlace
Artelo Enters Next Phase Of Evaluation Of Its Cannabinoid Receptor Targeting Drug For The Treatment Of Cancer-Related Anorexia And Weight Loss
April 26, 2023
Artelo Biosciences, Inc. (NASDAQ: ARTL), a clinical-stage pharmaceutical company focused on modulating lipid-signaling pathways to develop treatments for people living with cancer, pain, and...
Via
Benzinga
AstraZeneca, Ionis Unveil Complete Phase 3 Data For ATTR Candidate, Says Drug Halts Disease Progression
April 24, 2023
Via
Benzinga
NEURO-TTRansform Phase III results presented at AAN showed eplontersen demonstrated consistent and sustained improvement in all measures of disease and quality of life through 66 weeks
April 24, 2023
From
AstraZeneca
Via
Business Wire
Could This Rare-Disease Drug Candidate Become a Blockbuster?
April 19, 2023
This drug candidate could be a great treatment option for patients with a potentially deadly disease.
Via
The Motley Fool
Why AstraZeneca Shares Are Trading Higher Today?
April 18, 2023
AstraZeneca plc's (NASDAQ: AZN) vaccine head highlighted the confidence that the company's new COVID-19 antibody treatment could protect immunocompromised patients against all known virus variants.
Via
Benzinga
Cancer And Diabetes Remain Among The Deadliest And Most Debilitating Diseases — Is Gene Therapy The Solution? One Company, Genprex, Inc. (NASDAQ: GNPX), Thinks So
April 18, 2023
On their own, cancer or diabetes can be debilitating and deadly. The two are common diseases with tremendous impact on health worldwide.
Via
Benzinga
< Previous
1
2
...
14
15
16
17
18
19
20
21
22
...
55
56
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.